EN
TR
Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient
Öz
COVID-19 (Coronavirus Disease-2019) which is dependent on SARS-CoV-2 (Severe Acute Respiratory Syndrome) virus started as a pandemic which affected every sphere of life. The disease progresses more heavily and higher mortality is observed in the COVID-19 patients who had cardiovascular disease before or cardiovascular risk factors (smoking habit, male gender, old age, obesity, diabetes, hyperlipidemia and hypertension). Both COVID-19 disease and the drugs used during treatment lead to cardiac arrhythmia. In this study, a case that was followed up in intensive care unit because of COVID-19 disease and had ventricular tachycardia following Tocilizumab treatment was presented.
Anahtar Kelimeler
Destekleyen Kurum
yok
Proje Numarası
yok
Kaynakça
- REFERANS 1- COVID-19 and Cardiovascular System: Approach of Adult and Pediatric Cardiology Meltem REFİKER EGE1 , Feyza Ayşenur PAÇ2. Journal of Health Science Yuksek Ihtisas University. P-ISSN: 2717-8439. YIU Saglik Bil Derg 2020;1:24−30. REFERANS 2- Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the Cardiovascular System. Nat Rev Cardiol 2020;17(5):259-60.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Klinik Tıp Bilimleri
Bölüm
Olgu Sunumu
Yayımlanma Tarihi
30 Eylül 2022
Gönderilme Tarihi
5 Ocak 2022
Kabul Tarihi
22 Nisan 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 6 Sayı: 2
APA
İncaman, D., & Çınar, M. (2022). Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient. Balıkesir Medical Journal, 6(2), 22-28. https://doi.org/10.33716/bmedj.1053956
AMA
1.İncaman D, Çınar M. Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient. BMedJ. 2022;6(2):22-28. doi:10.33716/bmedj.1053956
Chicago
İncaman, Deniz, ve Mahmut Çınar. 2022. “Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient”. Balıkesir Medical Journal 6 (2): 22-28. https://doi.org/10.33716/bmedj.1053956.
EndNote
İncaman D, Çınar M (01 Eylül 2022) Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient. Balıkesir Medical Journal 6 2 22–28.
IEEE
[1]D. İncaman ve M. Çınar, “Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient”, BMedJ, c. 6, sy 2, ss. 22–28, Eyl. 2022, doi: 10.33716/bmedj.1053956.
ISNAD
İncaman, Deniz - Çınar, Mahmut. “Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient”. Balıkesir Medical Journal 6/2 (01 Eylül 2022): 22-28. https://doi.org/10.33716/bmedj.1053956.
JAMA
1.İncaman D, Çınar M. Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient. BMedJ. 2022;6:22–28.
MLA
İncaman, Deniz, ve Mahmut Çınar. “Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient”. Balıkesir Medical Journal, c. 6, sy 2, Eylül 2022, ss. 22-28, doi:10.33716/bmedj.1053956.
Vancouver
1.Deniz İncaman, Mahmut Çınar. Tocilizumab-Associated Ventricular Tachycardia Case in a COVID-19 Patient. BMedJ. 01 Eylül 2022;6(2):22-8. doi:10.33716/bmedj.1053956
